1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus
(
- Contribution to journal › Article
- 2019
-
Mark
Elevated circulating effector memory T cells but similar levels of regulatory T cells in patients with type 2 diabetes mellitus and cardiovascular disease
(
- Contribution to journal › Article
-
Mark
Lack of Ability to Present Antigens on Major Histocompatibility Complex Class II Molecules Aggravates Atherosclerosis in ApoE-/- Mice
(
- Contribution to journal › Article
- 2018
-
Mark
B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice
(
- Contribution to journal › Article
- 2016
-
Mark
CD4(+) CD56(+) natural killer T-like cells secreting interferon-γ are associated with incident coronary events.
(
- Contribution to journal › Article
- 2015
-
Mark
IL-22 affects smooth muscle cell phenotype and plaque formation in apolipoprotein E knockout mice.
(
- Contribution to journal › Article
- 2013
-
Mark
T-Helper 2 Immunity Is Associated With Reduced Risk of Myocardial Infarction and Stroke.
2013) In Arteriosclerosis, Thrombosis and Vascular Biology(
- Contribution to journal › Article
- 2012
-
Mark
Low Levels of Circulating CD4+FoxP3+ T Cells Are Associated With an Increased Risk for Development of Myocardial Infarction But Not for Stroke.
(
- Contribution to journal › Article
- 2011
-
Mark
Immunization with cationized BSA inhibits progression of disease in ApoBec-1/LDL receptor deficient mice with manifest atherosclerosis.
(
- Contribution to journal › Article
-
Mark
Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine.
(
- Contribution to journal › Article